GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.3201
-0.0021 (-0.65%)
At close: Oct 2, 2026, 4:00 PM EDT
0.3137
-0.0064 (-2.00%)
After-hours: Oct 2, 2026, 7:47 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $2.91 million as of October 2, 2026. Its market cap has decreased by -81.82% in one year.
Market Cap
2.91M
Enterprise Value
90.67K
1-Year Change
-81.82%
Ranking
Category
Stock Price
$0.32
ChartMarket Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $2.91M, an increase of 1,113.50%. That is a compound annual growth rate of 42.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.91M | -60.37% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 3.23M |
| Propanc Biopharma | 3.17M |
| Cadrenal Therapeutics | 3.15M |
| Addex Therapeutics | 3.13M |
| Revelation Biosciences | 3.11M |
| HCW Biologics | 3.10M |
| VivoSim Labs | 2.91M |
| Onconetix | 2.84M |